Literature DB >> 8522318

ACP1 and human adaptability. 1. Association with common diseases: a case-control study.

E Bottini1, F Gloria-Bottini, P Borgiani.   

Abstract

Human red cell acid phosphatase (ACP1) is a polymorphic enzyme closely related to cytosolic low molecular weight acid phosphatases, a protein family broadly conserved among eukaryotes. Two different functions have been proposed for ACP1: flavin mononucleotide (FMN) phosphatase and phosphotyrosine phosphatase (PTPase). Given that genetic variants of ACP1 activity are common, the enzyme could have a role in regulating a large spectrum of cellular functions and, in turn, disease susceptibility. In the present paper we report a study of ACP1 genetic polymorphism in 1088 normal subjects and in 1267 subjects from the population of Rome admitted to hospital for a number of common diseases. All ACP1 parameters investigated show highly significant differences among samples, suggesting that the enzyme may have a significant role in some of the diseases considered. In particular, consistent associations of ACP1 with developmental disturbances and with hemolytic favism have been observed. In the majority of diseases showing association with ACP1, only one of the two ACP1 isoforms, f and s, is involved, supporting the hypothesis of a functional differentiation between the two enzymatic fractions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522318     DOI: 10.1007/bf00210290

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  46 in total

1.  Dephosphorylation of tyrosine phosphorylated synthetic peptides by rat liver phosphotyrosine protein phosphatase isoenzymes.

Authors:  M Stefani; A Caselli; M Bucciantini; L Pazzagli; F Dolfi; G Camici; G Manao; G Ramponi
Journal:  FEBS Lett       Date:  1993-07-12       Impact factor: 4.124

2.  The rare "silent" allele P O or P V (P Vienna ) of human red cell acid phosphatase, typed in a second family.

Authors:  J Herbich; K Meinhart
Journal:  Humangenetik       Date:  1972

3.  Studies of the in vitro effects of oxidized glutathione and acetylphenylhydrazine on acid phosphatases of human red blood cells. An experimental model for the investigation of hemolytic drug action at the molecular level.

Authors:  E Bottini; G Modiano; C Santolamazza; G Filippi; L Businco
Journal:  Clin Chim Acta       Date:  1971-01       Impact factor: 3.786

4.  The discovery of the red cell acid phosphatase polymorphism.

Authors:  D A Hopkinson
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

5.  ACP1GUA-1--a low-activity variant of human erythrocyte acid phosphatase: association with increased glutathione reductase activity.

Authors:  H W Mohrenweiser; J E Novotny
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

6.  Effect of oxidized glutathione on human red cell acid phosphatases.

Authors:  E Bottini; G Modiano
Journal:  Biochem Biophys Res Commun       Date:  1964-10-14       Impact factor: 3.575

7.  Rat liver low M(r) phosphotyrosine protein phosphatase isoenzymes: purification and amino acid sequences.

Authors:  G Manao; L Pazzagli; P Cirri; A Caselli; G Camici; G Cappugi; A Saeed; G Ramponi
Journal:  J Protein Chem       Date:  1992-06

Review 8.  Chromosome maps of man and mouse. IV.

Authors:  A G Searle; J Peters; M F Lyon; J G Hall; E P Evans; J H Edwards; V J Buckle
Journal:  Ann Hum Genet       Date:  1989-05       Impact factor: 1.670

9.  Enzyme polymorphism and clinical variability of diseases: study of acid phosphatase locus 1 (ACP1) in obese subjects.

Authors:  E Bottini; N Lucarini; G Gerlini; G Finocchi; G Sciré; F Gloria-Bottini
Journal:  Hum Biol       Date:  1990-06       Impact factor: 0.553

10.  Further studies on acid phosphatase in obese subjects.

Authors:  A Paggi; P Borgiani; F Gloria-Bottini; S Russo; I Saponara; M Banci; A Amante; N Lucarini; E Bottini
Journal:  Dis Markers       Date:  1991 Jan-Feb       Impact factor: 3.434

View more
  7 in total

Review 1.  Acid phosphatases.

Authors:  H Bull; P G Murray; D Thomas; A M Fraser; P N Nelson
Journal:  Mol Pathol       Date:  2002-04

Review 2.  The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesis.

Authors:  Irina Alho; Luís Costa; Manuel Bicho; Constança Coelho
Journal:  Tumour Biol       Date:  2013-04-14

3.  Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans.

Authors:  Yu-Hsiang Shu; Jaana Hartiala; Anny H Xiang; Enrique Trigo; Jean M Lawrence; Hooman Allayee; Thomas A Buchanan; Nunzio Bottini; Richard M Watanabe
Journal:  J Clin Endocrinol Metab       Date:  2009-07-21       Impact factor: 5.958

4.  Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients.

Authors:  María Teruel; Jose-Ezequiel Martin; Carlos González-Juanatey; Raquel López-Mejias; Jose A Miranda-Filloy; Ricardo Blanco; Alejandro Balsa; Dora Pascual-Salcedo; Luis Rodriguez-Rodriguez; Benjamin Fernández-Gutierrez; Ana M Ortiz; Isidoro González-Alvaro; Carmen Gómez-Vaquero; Nunzio Bottini; Javier Llorca; Miguel A González-Gay; Javier Martin
Journal:  Arthritis Res Ther       Date:  2011-07-18       Impact factor: 5.156

5.  ACP1 Genetic Polymorphism and Coronary Artery Disease: Evidence of Effects on Clinical Parameters of Cardiac Function.

Authors:  Fulvia Gloria-Bottini; Maria Banci; Patrizia Saccucci; Paolo Nardi; Mattia Scognamiglio; Federica Papetti; Sara Adanti; Andrea Magrini; Antonio Pellegrino; Egidio Bottini; Luigi Chiariello
Journal:  Cardiol Res       Date:  2013-07-11

6.  Low molecular weight protein tyrosine phosphatase isoforms regulate breast cancer cells migration through a RhoA dependent mechanism.

Authors:  Irina Alho; Luis Costa; Manuel Bicho; Constança Coelho
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

Review 7.  Protein tyrosine phosphatases in cardiac physiology and pathophysiology.

Authors:  Fallou Wade; Karim Belhaj; Coralie Poizat
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.